Grants / Office of National Drug Control Policy / Office of National Drug Control Policy

EDSUSS-2021: Emergency Department Substance Use Surveillance System

Closed Closed August 27, 2021 Opportunity EDSUSS-2021 ☆ Save

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of National Drug Control Policy notices from 2021.

• Award ceiling$300,000
• Award floor$100,000
• Expected awards1
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to nonprofits and colleges and universities.

• Public and State controlled institutions of higher education
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

More grants for nonprofits, colleges and universities.

Is this a realistic fit?

• Past Research and Data Analysis awards averaged $915,665; this notice allows up to $300,000 per award.
• Most of the program's money (65% over five years) went to state and local governments.
• No cost sharing or match is required.

What the grant funds

Overview This project seeks to refine and geographically expand a methodology for obtaining drug early warning indicators from expanded testing of urine samples that were previously collected and tested as part of an existing drug test protocol. This method was initially developed using local criminal justice populations – including persons in pre-trial or lock-up, parolees or probationers, and drug court participants. Similar methodology is promising for use in other venues, such as in trauma units and emergency departments, where biological samples are often collected from patients. ONDCP seeks to apply this methodology to emergency department populations. (See Dezman et al., 2020, High Prevalence of Fentanyl Detected by the Maryland Emergency Department Drug Surveillance System — Baltimore, Maryland, 2019, Mortality and Morbidity Weekly Report, June 12, 69:20 724-26, available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315791/). ONDCP seeks to expand this methodology beyond Maryland to a purposive sample of emergency department populations throughout the United States to determine the extent of geographic variability in the outcome of testing for an expanded panel of illicit drugs. Before the specimens are discarded, this project will re-test them for an expanded panel of drugs. The awardee will work with ONDCP to determine specific metabolites to include in the expanded test panel beyond the NIDA-5 drugs, including synthetic cannabinoids and opioids. The awardee will also establish working relationships with emergency departments that can provide the specimens to be re-tested in this project. Analysis of the expanded drug test results will provide essential information on what old and new illicit drugs are detected or missed by conventional testing protocols, and how the drug patterns might vary by subpopulation and geography. Bypassing the expense of collecting the original specimens and re-using those that have already been tested with known results yields a relatively inexpensive and timely picture of emerging drugs in a given subpopulation and locality. Authorizing Statutes and Governing Regulations Applicable to this Funding Opportunity: The authority for this opportunity is the SUPPORT for Patients and Communities Act, (Pub. L. No. 115-271), 21 U.S.C. §§ 1701 et seq. and applicable appropriations statutes providing funding to ONDCP for this purpose.

Category: Health.

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.